{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02580695",
      "OrgStudyIdInfo": {
        "OrgStudyId": "C4COA01"
      },
      "Organization": {
        "OrgFullName": "Universidad de los Andes, Chile",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis",
      "OfficialTitle": "A Phase I/II, Randomized, Double-blind, Controlled Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UC-MSCs) in Patients With Knee Osteoarthritis"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2018",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "October 15, 2015",
      "StudyFirstSubmitQCDate": "October 19, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 20, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 24, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 26, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor-Investigator",
        "ResponsiblePartyInvestigatorFullName": "Francisco Espinoza, MD",
        "ResponsiblePartyInvestigatorTitle": "Alternative Investigator",
        "ResponsiblePartyInvestigatorAffiliation": "Universidad de los Andes, Chile"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Francisco Espinoza, MD",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Knee-osteoarthritis (OA) is a common and disabling problem, that represents a global health issue since none of the current therapies are truly disease modifying. The use of mesenchymal stem cells (MSCs) in OA-preclinical models has been associated with a reduction in cartilage degradation, the attenuation of bone sclerosis and an effective anti-inflammatory response. Investigators have designed a randomized phase I/II placebo controlled trial of UC-MSCs in knee OA. Outcomes will be evaluated at 12 months, comparing monodosis versus double intra-articular injection, re-randomized at 6 months."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Osteoarthritis"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "30",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Umbilical-cord mesenchymal stromal cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Umbilical-cord mesenchymal stromal cells (UC-MSCs)\n\nAllogeneic UC-MSCs 20 x 10e6 diluted on 3 mL of saline solution + 5% of Plasma AB\n\nArm 2a: single infusion group. UC-MSCs at 0 month\n\nArm 2b: double infusion group. UC-MSCs at 0 and 6 months",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: umbilical-cord mesenchymal stromal cells"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hyaluronic Acid (HA)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Drug: Hyaluronic Acid 3 mL of HA intra-articular injection at baseline and 6 months",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Hyaluronic Acid"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "umbilical-cord mesenchymal stromal cells",
            "InterventionDescription": "Intra-articular knee injection of UC-MSC 20x10e6 at 0 and 6 months",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Umbilical-cord mesenchymal stromal cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "UC-MSCs"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Hyaluronic Acid",
            "InterventionDescription": "Intra-articular knee injection of Hyaluronic Acid (3ml) at 0 and 6 months",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hyaluronic Acid (HA)"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Durolane"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Proportion of patients who experience an adverse event",
            "PrimaryOutcomeDescription": "according to National Cancer Institute Common Terminology Criteria for Adverse Effects (NCI-CTCAE)",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Physical function improvement measured by WOMAC OA index",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Change in pain density measured by Visual analogue scale (VAS)",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "QoL improvement measured by SF-36",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Changes in WORMS scale measured by knee MRI",
            "SecondaryOutcomeTimeFrame": "12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSymptomatic Knee OA, Kellgren and Lawrence grade I, II, III on plain Rx films.\nChondromalacia patella grade I-III on knee MRI. With or without meniscal tear.\nStable knee and normal clinical exam of involved extremity\nWritten informed consent for patients.\n\nExclusion Criteria:\n\nBilateral symptomatic knee OA\nLocal or systemic infection.\nActive neoplasia or immunosuppressive state\nPregnancy or Breastfeeding\nBody Mass Index â‰¥ 30\nPresence of Pacemaker or Lower extremity metal implant\nAnticoagulant treatment other than aspirin.\nRecent use of oral (previous month) or intra-articular (previous 3 months) corticosteroids\nConcomitant inflammatory joint disease (cristal, connective tissue disease)\nValgus (>10o) or Varus (>5o) deformity of involved extremity\nCondilar or Tibial plateau Generalized Bone Marrow edema on MRI\nSignificant symptomatic hip or spine disease\nSignificant abnormality in baseline lab tests",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "70 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Jose Matas, MD",
            "OverallOfficialAffiliation": "Universidad de los Andes",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Clinica Universidad de los Andes",
            "LocationCity": "Santiago",
            "LocationCountry": "Chile"
          }
        ]
      }
    }
  },
  "AnnotationSection": {
    "AnnotationModule": {
      "UnpostedAnnotation": {
        "UnpostedResponsibleParty": "Francisco Espinoza, Alternative Investigator, Universidad de los Andes, Chile",
        "UnpostedEventList": {
          "UnpostedEvent": [
            {
              "UnpostedEventType": "Release",
              "UnpostedEventDate": "January 17, 2019"
            },
            {
              "UnpostedEventType": "Reset",
              "UnpostedEventDate": "April 12, 2019"
            }
          ]
        }
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000010003",
            "ConditionMeshTerm": "Osteoarthritis"
          },
          {
            "ConditionMeshId": "D000020370",
            "ConditionMeshTerm": "Osteoarthritis, Knee"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000001168",
            "ConditionAncestorTerm": "Arthritis"
          },
          {
            "ConditionAncestorId": "D000007592",
            "ConditionAncestorTerm": "Joint Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          },
          {
            "ConditionAncestorId": "D000012216",
            "ConditionAncestorTerm": "Rheumatic Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12078",
            "ConditionBrowseLeafName": "Osteoarthritis",
            "ConditionBrowseLeafAsFound": "Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21321",
            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3628",
            "ConditionBrowseLeafName": "Arthritis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9773",
            "ConditionBrowseLeafName": "Joint Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14197",
            "ConditionBrowseLeafName": "Rheumatic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5475",
            "ConditionBrowseLeafName": "Collagen Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionMeshList": {
        "InterventionMesh": [
          {
            "InterventionMeshId": "D000006820",
            "InterventionMeshTerm": "Hyaluronic Acid"
          }
        ]
      },
      "InterventionAncestorList": {
        "InterventionAncestor": [
          {
            "InterventionAncestorId": "D000000276",
            "InterventionAncestorTerm": "Adjuvants, Immunologic"
          },
          {
            "InterventionAncestorId": "D000007155",
            "InterventionAncestorTerm": "Immunologic Factors"
          },
          {
            "InterventionAncestorId": "D000045505",
            "InterventionAncestorTerm": "Physiological Effects of Drugs"
          },
          {
            "InterventionAncestorId": "D000055675",
            "InterventionAncestorTerm": "Viscosupplements"
          },
          {
            "InterventionAncestorId": "D000020011",
            "InterventionAncestorTerm": "Protective Agents"
          }
        ]
      },
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M9030",
            "InterventionBrowseLeafName": "Hyaluronic Acid",
            "InterventionBrowseLeafAsFound": "Ophthalmic",
            "InterventionBrowseLeafRelevance": "high"
          },
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M2780",
            "InterventionBrowseLeafName": "Adjuvants, Immunologic",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9353",
            "InterventionBrowseLeafName": "Immunologic Factors",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M27448",
            "InterventionBrowseLeafName": "Viscosupplements",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M21022",
            "InterventionBrowseLeafName": "Protective Agents",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          },
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          }
        ]
      }
    }
  }
}